Cancel
Michal Silverberg
Managing Director, Novartis Venture Fund, Board Director
@
GentiBio
About Michal Silverberg
Michal Silverberg is the Managing Director at Novartis Venture Fund and a Board Director, holding both an MBA and an MS degree.
Known information
Michal Silverberg serves as the Managing Director at Novartis Venture Fund, where she plays a pivotal role in steering the company’s investment strategies in the healthcare and pharmaceutical sectors. In addition to her leadership role at Novartis Venture Fund, she also holds a position as a Board Director. Silverberg’s academic background includes an MBA and an MS degree, equipping her with a robust foundation in both business administration and science, which she leverages to drive innovation and strategic investments in her field.
About GentiBio
GentiBio is a biotech company focused on developing engineered T regulatory cell therapies for various immune and inflammatory diseases, with its lead product GNTI-122 targeting type 1 diabetes.
Report inaccurate information
